It is therefore unclear if necroptosis or RIPK3-activation independent of cell death modulates the immune system and explains the protective effects of RIPK3-deficient mice in ischemic injury and other diseases, such as the TNFα-mediated shock (SIRS) or ischemia-reperfusion injury (IRI). The gene discussed is RIPK3; the disease is ischemia.